JMP Securities maintained a positive outlook on Kalvista Pharmaceuticals Inc (NASDAQ:KALV), reiterating a Market Outperform ...
JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...
With Tesla (TSLA) planning to launch unsupervised full self-driving as a paid service in Austin in June and in California by year end while ...
JMP Securities analyst Jonathan Wolleben initiated coverage of Astria Therapeutics (ATXS) with an Outperform rating and $26 price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback